These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9753076)

  • 1. Factor V Leiden haplotypes in two homozygotes of Asian origin.
    Rees DC; Clarke K; Martin PG; Keeling DM
    Br J Haematol; 1998 Sep; 102(5):1381-2. PubMed ID: 9753076
    [No Abstract]   [Full Text] [Related]  

  • 2. Central retinal artery occlusion in a patient homozygous for factor V Leiden.
    Larsson J
    Am J Ophthalmol; 2000 Jun; 129(6):816-7. PubMed ID: 10927002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How old is factor V Leiden mutation?
    Pawar AR; Shetty S; Ghosh K; Mohanty D
    Thromb Haemost; 2001 Dec; 86(6):1591-2. PubMed ID: 11776338
    [No Abstract]   [Full Text] [Related]  

  • 4. Activated protein C resistance in the Japanese population due to homozygosity for the factor V R2 haplotype.
    Okada H; Toyoda Y; Takagi A; Saito H; Kojima T; Yamazaki T
    Int J Hematol; 2010 Apr; 91(3):549-50. PubMed ID: 20300981
    [No Abstract]   [Full Text] [Related]  

  • 5. Heterogeneity of activated protein C resistance phenotype in subjects with compound heterozygosity for HR2 haplotype and FV Leiden mutation (R506Q) in factor V gene.
    Castaman G; Ruggeri M; Tosetto A; Rodeghiero F
    Thromb Haemost; 2000 Aug; 84(2):357-8. PubMed ID: 10959717
    [No Abstract]   [Full Text] [Related]  

  • 6. Coagulation factor V Leiden mutation was detected in the patients with activated protein C resistance in Thailand.
    Arnutti P; Hiyoshi M; Prayoonwiwat W; Nathalang O; Suwanasophon C; Kokaseam R; Tatsumi N
    Thromb Haemost; 1998 Aug; 80(2):344-5. PubMed ID: 9716166
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenotype and genotype expression in pseudohomozygous R2 factor V.
    Kalafatis M; Simioni P; Bernardi F
    Blood; 2001 Sep; 98(6):1988-9. PubMed ID: 11565539
    [No Abstract]   [Full Text] [Related]  

  • 8. Cerebral venous thrombosis associated to homozygous factor V Leiden mutation in a female of Syrian origin.
    Mira Y; Alfaro A; Estellés A; Vayá A; Ferrando F; Villa P
    Haematologica; 2002 Jan; 87(1):ELT02. PubMed ID: 11801486
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of exogenous estrogen on atherothrombotic vascular disease risk related to the presence or absence of the factor V Leiden mutation (resistance to activated protein C).
    Glueck CJ; Wang P; Fontaine RN; Tracy T; Sieve-Smith L; Lang JE
    Am J Cardiol; 1999 Sep; 84(5):549-54. PubMed ID: 10482153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpreting results from Factor V Leiden mutation analysis: a cautionary note.
    Sinclair GD; Poon MC
    Clin Appl Thromb Hemost; 2013; 19(1):106-7. PubMed ID: 23034579
    [No Abstract]   [Full Text] [Related]  

  • 11. [Idiopathic intracranial hypertension and factor V Leiden mutation].
    Younes S; Aissi M; Chérif Y; Daoussi N; Boughammoura A; Frih Ayed M; Sfar MH; Jerbi S
    J Mal Vasc; 2014 Jul; 39(4):270-3. PubMed ID: 24908418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular implications of the factor V Leiden mutation.
    Major DA; Sane DC; Herrington DM
    Am Heart J; 2000 Aug; 140(2):189-95. PubMed ID: 10925328
    [No Abstract]   [Full Text] [Related]  

  • 13. Activated protein C resistance, factor V Leiden, and retinal vessel occlusion.
    Ma AD; Abrams CS
    Retina; 1998; 18(4):297-300. PubMed ID: 9730170
    [No Abstract]   [Full Text] [Related]  

  • 14. Allelic discrimination of factor V Leiden using the GeneAmp 5700 Sequence Detection System.
    Monk SE; Duckworth AW; Farrugia J; Copplestone JA; Rule SA
    Thromb Haemost; 2002 Dec; 88(6):1071-2. PubMed ID: 12529765
    [No Abstract]   [Full Text] [Related]  

  • 15. Factor V Leiden mutation in one family of Chinese origin.
    Wu J; Gu J; Xu J; Wang J; Sun Z; Smirnov MD; Morrissey JH; Esmon N
    Chin Med J (Engl); 2001 Apr; 114(4):379-81. PubMed ID: 11780458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage.
    Rai R; Shlebak A; Cohen H; Backos M; Holmes Z; Marriott K; Regan L
    Hum Reprod; 2001 May; 16(5):961-5. PubMed ID: 11331645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated protein C resistance assay and factor V Leiden.
    Prüller F; Weiss EC; Raggam RB; Cervar-Zivkovic M; Renner W; Wagner J; Michaelis S; März W; Mangge H
    N Engl J Med; 2014 Aug; 371(7):685-6. PubMed ID: 25119624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of activated protein C resistance due to factor V leiden mutation in cases of intrauterine fetal death.
    Rothbart H; Ohel G; Younis J; Lanir N; Brenner B
    J Matern Fetal Med; 1999; 8(5):228-30. PubMed ID: 10475506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of factor V Leiden mutation in Yugoslav thrombophilic patients and its relationship to the laboratory diagnosis of APC resistance.
    Mikovic D; Rakicevic L; Kovac M; Radojkovic D
    Thromb Haemost; 2000 Oct; 84(4):723-4. PubMed ID: 11057877
    [No Abstract]   [Full Text] [Related]  

  • 20. Arterial vascular occlusion associated with factor V Leiden gene mutation.
    Tayyanipour R; Pulido JS; Postel EA; Lipkowitz JL; Pisciotta A; Braza E
    Retina; 1998; 18(4):376-7. PubMed ID: 9730184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.